Matteo Marasco | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management	FRONTIERS IN MEDICINE	2024
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection	JOURNAL OF CLINICAL MEDICINE	2024
Gastrointestinal side effects of somatostatin analogs in neuroendocrine tumors: a focused review	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY	2024
Sarcopenia in patients with advanced gastrointestinal well-differentiated neuroendocrine tumors	NUTRIENTS	2024
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs	JOURNAL OF NEUROENDOCRINOLOGY	2024
Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review	CANCERS	2024
Management of functional pancreatic neuroendocrine neoplasms	CURRENT TREATMENT OPTIONS IN ONCOLOGY	2023
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia	ENDOCRINE	2023
When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?	JOURNAL OF CLINICAL MEDICINE	2023
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY	2023
Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer	THE AMERICAN JOURNAL OF GASTROENTEROLOGY	2023
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors	ENDOCRINE	2022
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors	LA RADIOLOGIA MEDICA	2022
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors. A Systematic Review and Meta-Analysis	JOURNAL OF CLINICAL MEDICINE	2022